Conservest Capital Advisors’s Oracle ORCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$259K Buy
1,886
+173
+10% +$24.4K 0.02% 125
2026
Q2
$251K Buy
1,713
+105
+7% +$19K 0.02% 122
2026
Q1
$237K Buy
1,608
+24
+2% +$3.9K 0.02% 119
2025
Q4
$309K Buy
1,584
+8
+0.5% +$1.9K 0.03% 100
2025
Q3
$443K Buy
1,576
+11
+0.7% +$2.8K 0.04% 85
2025
Q2
$342K Buy
1,565
+38
+2% +$6.14K 0.03% 94
2025
Q1
$213K Hold
1,527
– – 0.02% 106
2024
Q4
$254K Buy
+1,527
New +$271K 0.03% 96

Other funds holding ORCL

Conservest Capital Advisors's ORCL Position: Q3 2026 in Review

Conservest Capital Advisors increased its Oracle (ORCL) stake by 10% in Q3 2026, buying an estimated $24.4K and bringing the position to 1,886 shares worth $259K. The position accounts for 0.02% of the portfolio, ranked #125.

Conservest Capital Advisors first reported a position in ORCL in Q4 2024 and has held it in 8 quarters since. The position peaked at $443K in Q3 2025. 3,421 funds tracked by Wall St. Rank hold ORCL as of Q3 2026.

  • Conservest Capital Advisors held 1,886 shares of Oracle worth $259K as of Q3 2026.
  • Conservest Capital Advisors bought 173 Oracle shares in Q3 2026, an estimated $24.4K.
  • Oracle made up 0.02% of Conservest Capital Advisors's portfolio in Q3 2026, its #125 holding.
  • Conservest Capital Advisors first reported a position in Oracle in Q4 2024 and has held it in 8 quarters since.
  • Conservest Capital Advisors's Oracle position peaked at $443K in Q3 2025.
  • 3,421 funds tracked by Wall St. Rank held Oracle as of Q3 2026.

Based on Conservest Capital Advisors's 13F filing for Q3 2026, filed 9 Nov 2026.